482 related articles for article (PubMed ID: 38515791)
1. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism.
Hashem M; Mohandesi Khosroshahi E; Aliahmady M; Ghanei M; Soofi Rezaie Y; Alsadat Jafari Y; Rezaei F; Khodaparast Eskadehi R; Kia Kojoori K; Jamshidian F; Nabavi N; Rashidi M; Hasani Sadi F; Taheriazam A; Entezari M
Noncoding RNA Res; 2024 Jun; 9(2):560-582. PubMed ID: 38515791
[TBL] [Abstract][Full Text] [Related]
2. The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms.
Rezaee M; Mohammadi F; Keshavarzmotamed A; Yahyazadeh S; Vakili O; Milasi YE; Veisi V; Dehmordi RM; Asadi S; Ghorbanhosseini SS; Rostami M; Alimohammadi M; Azadi A; Moussavi N; Asemi Z; Aminianfar A; Mirzaei H; Mafi A
Front Pharmacol; 2023; 14():1152672. PubMed ID: 37153758
[TBL] [Abstract][Full Text] [Related]
3. Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells.
Zangouei AS; Rahimi HR; Mojarrad M; Moghbeli M
Diagn Pathol; 2020 Nov; 15(1):136. PubMed ID: 33183321
[TBL] [Abstract][Full Text] [Related]
4. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Derived Exosomal Non-Coding RNAs: The Emerging Mechanisms and Potential Clinical Applications in Breast Cancer.
Yi Y; Wu M; Zeng H; Hu W; Zhao C; Xiong M; Lv W; Deng P; Zhang Q; Wu Y
Front Oncol; 2021; 11():738945. PubMed ID: 34707990
[TBL] [Abstract][Full Text] [Related]
6. The Role of Non-Coding RNAs in Breast Cancer Drug Resistance.
Tian JH; Liu SH; Yu CY; Wu LG; Wang LB
Front Oncol; 2021; 11():702082. PubMed ID: 34589423
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer.
Lu M; Zhan H; Liu B; Li D; Li W; Chen X; Zhou X
EPMA J; 2021 Dec; 12(4):589-604. PubMed ID: 34950253
[TBL] [Abstract][Full Text] [Related]
8. Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.
Ashekyan O; Abdallah S; Shoukari AA; Chamandi G; Choubassy H; Itani ARS; Alwan N; Nasr R
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955480
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
Fanale D; Castiglia M; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
[TBL] [Abstract][Full Text] [Related]
10. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
Okamura S; Yoshino H; Kuroshima K; Tsuruda M; Osako Y; Sakaguchi T; Yonemori M; Yamada Y; Tatarano S; Nakagawa M; Enokida H
BMC Cancer; 2021 Jan; 21(1):48. PubMed ID: 33430801
[TBL] [Abstract][Full Text] [Related]
11. Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
Pietzak EJ; Zabor EC; Bagrodia A; Armenia J; Hu W; Zehir A; Funt S; Audenet F; Barron D; Maamouri N; Li Q; Teo MY; Arcila ME; Berger MF; Schultz N; Dalbagni G; Herr HW; Bajorin DF; Rosenberg JE; Al-Ahmadie H; Bochner BH; Solit DB; Iyer G
Eur Urol; 2019 Feb; 75(2):231-239. PubMed ID: 30290956
[TBL] [Abstract][Full Text] [Related]
12. Roles of non-coding RNAs in the metabolism and pathogenesis of bladder cancer.
Sanya DRA; Onésime D
Hum Cell; 2023 Jul; 36(4):1343-1372. PubMed ID: 37209205
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs: Key Players in Bladder Cancer.
Li Q; Wang H; Peng H; Huang Q; Huyan T; Huang Q; Yang H; Shi J
Mol Diagn Ther; 2019 Oct; 23(5):579-601. PubMed ID: 31325035
[TBL] [Abstract][Full Text] [Related]
14. TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC).
Bunch B; Krishnan N; Greenspan RD; Ramakrishnan S; Attwood K; Yan L; Qi Q; Wang D; Morrison C; Omilian A; Bshara W; Pili R; Trump DL; Johnson C; Woloszynska A
Cell Cycle; 2019 Sep; 18(17):2055-2066. PubMed ID: 31318640
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies.
Mirzaei S; Paskeh MDA; Hashemi F; Zabolian A; Hashemi M; Entezari M; Tabari T; Ashrafizadeh M; Raee P; Aghamiri S; Aref AR; Leong HC; Kumar AP; Samarghandian S; Zarrabi A; Hushmandi K
Life Sci; 2022 Jan; 288():119948. PubMed ID: 34520771
[TBL] [Abstract][Full Text] [Related]
16. miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer.
Nordentoft I; Birkenkamp-Demtroder K; Agerbæk M; Theodorescu D; Ostenfeld MS; Hartmann A; Borre M; Ørntoft TF; Dyrskjøt L
BMC Med Genomics; 2012 Sep; 5():40. PubMed ID: 22954303
[TBL] [Abstract][Full Text] [Related]
17. Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance.
Zhu KP; Zhang CL; Ma XL; Hu JP; Cai T; Zhang L
Mol Ther; 2019 Mar; 27(3):518-530. PubMed ID: 30692017
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
[TBL] [Abstract][Full Text] [Related]
19. Drug resistance in breast cancer is based on the mechanism of exocrine non-coding RNA.
Ye S; Chen S; Yang X; Lei X
Discov Oncol; 2024 May; 15(1):138. PubMed ID: 38691224
[TBL] [Abstract][Full Text] [Related]
20. Transactivation of PTGS2 by PAX5 signaling potentiates cisplatin resistance in muscle-invasive bladder cancer cells.
Dong BW; Zhang WB; Qi SM; Yan CY; Gao J
Biochem Biophys Res Commun; 2018 Sep; 503(4):2293-2300. PubMed ID: 29964012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
